Practical guidelines on the use of insulin lispro in elderly diabetic patients

Mahmoud M. Benbarka, Pamela T Prescott, Thomas T. Aoki

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Glucose tolerance deteriorates, and the prevalence of diabetes mellitus increases, with advancing age. Most elderly diabetic patients have type 2 (non-insulin-dependent) diabetes mellitus, but the prolonged survival of young people with type 1 (insulin-dependent) diabetes mellitus increases the prevalence of type 1 diabetes among the elderly. Approximately 25 to 29% of patients with type 2 diabetes mellitus are treated with insulin. Conventional therapy with regular and intermediate-acting insulin preparations does not mimic physiological insulin secretion. Subcutaneous administration of insulin lispro, a recently introduced insulin analogue, more closely mimics the time-action curve of endogenous insulin that is produced in response to meals. Its rapid onset and short duration of action allow for adequate control of postprandial glucose levels while reducing the risk of late postprandial hypoglycaemia. Insulin lispro offers improved glycaemic control, convenience and increased flexibility in insulin-treated patients with diabetes.

Original languageEnglish (US)
Pages (from-to)103-113
Number of pages11
JournalDrugs and Aging
Volume12
Issue number2
DOIs
StatePublished - 1998

Fingerprint

Insulin Lispro
Guidelines
Insulin
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Glucose
Hypoglycemia
Meals
Diabetes Mellitus
Survival

ASJC Scopus subject areas

  • Pharmacology
  • Geriatrics and Gerontology

Cite this

Practical guidelines on the use of insulin lispro in elderly diabetic patients. / Benbarka, Mahmoud M.; Prescott, Pamela T; Aoki, Thomas T.

In: Drugs and Aging, Vol. 12, No. 2, 1998, p. 103-113.

Research output: Contribution to journalArticle

Benbarka, Mahmoud M. ; Prescott, Pamela T ; Aoki, Thomas T. / Practical guidelines on the use of insulin lispro in elderly diabetic patients. In: Drugs and Aging. 1998 ; Vol. 12, No. 2. pp. 103-113.
@article{30b3c098fbaa4e6fbc6aa8731372caf9,
title = "Practical guidelines on the use of insulin lispro in elderly diabetic patients",
abstract = "Glucose tolerance deteriorates, and the prevalence of diabetes mellitus increases, with advancing age. Most elderly diabetic patients have type 2 (non-insulin-dependent) diabetes mellitus, but the prolonged survival of young people with type 1 (insulin-dependent) diabetes mellitus increases the prevalence of type 1 diabetes among the elderly. Approximately 25 to 29{\%} of patients with type 2 diabetes mellitus are treated with insulin. Conventional therapy with regular and intermediate-acting insulin preparations does not mimic physiological insulin secretion. Subcutaneous administration of insulin lispro, a recently introduced insulin analogue, more closely mimics the time-action curve of endogenous insulin that is produced in response to meals. Its rapid onset and short duration of action allow for adequate control of postprandial glucose levels while reducing the risk of late postprandial hypoglycaemia. Insulin lispro offers improved glycaemic control, convenience and increased flexibility in insulin-treated patients with diabetes.",
author = "Benbarka, {Mahmoud M.} and Prescott, {Pamela T} and Aoki, {Thomas T.}",
year = "1998",
doi = "10.2165/00002512-199812020-00003",
language = "English (US)",
volume = "12",
pages = "103--113",
journal = "Drugs and Aging",
issn = "1170-229X",
publisher = "Adis International Ltd",
number = "2",

}

TY - JOUR

T1 - Practical guidelines on the use of insulin lispro in elderly diabetic patients

AU - Benbarka, Mahmoud M.

AU - Prescott, Pamela T

AU - Aoki, Thomas T.

PY - 1998

Y1 - 1998

N2 - Glucose tolerance deteriorates, and the prevalence of diabetes mellitus increases, with advancing age. Most elderly diabetic patients have type 2 (non-insulin-dependent) diabetes mellitus, but the prolonged survival of young people with type 1 (insulin-dependent) diabetes mellitus increases the prevalence of type 1 diabetes among the elderly. Approximately 25 to 29% of patients with type 2 diabetes mellitus are treated with insulin. Conventional therapy with regular and intermediate-acting insulin preparations does not mimic physiological insulin secretion. Subcutaneous administration of insulin lispro, a recently introduced insulin analogue, more closely mimics the time-action curve of endogenous insulin that is produced in response to meals. Its rapid onset and short duration of action allow for adequate control of postprandial glucose levels while reducing the risk of late postprandial hypoglycaemia. Insulin lispro offers improved glycaemic control, convenience and increased flexibility in insulin-treated patients with diabetes.

AB - Glucose tolerance deteriorates, and the prevalence of diabetes mellitus increases, with advancing age. Most elderly diabetic patients have type 2 (non-insulin-dependent) diabetes mellitus, but the prolonged survival of young people with type 1 (insulin-dependent) diabetes mellitus increases the prevalence of type 1 diabetes among the elderly. Approximately 25 to 29% of patients with type 2 diabetes mellitus are treated with insulin. Conventional therapy with regular and intermediate-acting insulin preparations does not mimic physiological insulin secretion. Subcutaneous administration of insulin lispro, a recently introduced insulin analogue, more closely mimics the time-action curve of endogenous insulin that is produced in response to meals. Its rapid onset and short duration of action allow for adequate control of postprandial glucose levels while reducing the risk of late postprandial hypoglycaemia. Insulin lispro offers improved glycaemic control, convenience and increased flexibility in insulin-treated patients with diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0031942792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031942792&partnerID=8YFLogxK

U2 - 10.2165/00002512-199812020-00003

DO - 10.2165/00002512-199812020-00003

M3 - Article

VL - 12

SP - 103

EP - 113

JO - Drugs and Aging

JF - Drugs and Aging

SN - 1170-229X

IS - 2

ER -